Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
about
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
@en
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
@nl
type
label
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
@en
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
@nl
prefLabel
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
@en
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
@nl
P1050
P3098
NCT03093428